Latest News Ophthalmologists Implant First Visian Toric ICLs in the U.S. By Staff Monday, November 5, 2018 12:24 AM MONROVIA, Calif.—STAAR Surgical Company announced the first patient implants of the its Visian Toric Implantable Collamer Lenses (TICLs) in the U.S. by Brinton Vision in St. Louis, Mo., and Parkhurst NuVision in San Antonio, Texas. The TICL was approved in the U.S. by the FDA on Sept.13, 2018, and the first patient implants occurred on Oct. 22, 2018. The Visian TICL has been approved and available for patients outside of the U.S. since 2002.“We are thrilled U.S. based ophthalmologists and their patients now have access to the TICL as STAAR Surgical marches toward a 1,000,000-lens sales milestone for its Visian ICL family of lenses,” said Caren Mason, president and CEO of STAAR Surgical Company. “The Visian ICL family of lenses offer patients visual freedom from spectacles and disposable contact lenses. The first Toric implants in the U.S. represent the initial steps in onboarding surgeons as we introduce this lens to more than 50 U.S. markets in the coming months. The Visian Toric ICL is big news for refractive surgeons and astigmatic patients in the U.S.”The Visian Toric ICL lens in the U.S. is indicated for patients 21 to 45 years of age for the correction of myopic astigmatism with spherical equivalent ranging from -3.0 D to ≤ -15.0 D (in the spectacle plane) with cylinder (spectacle plane) of 1.0 D to 4.0 D in the spectacle plane. The Visian ICL family of lens are intended for placement in the posterior chamber of the eye without removing corneal tissue or the natural crystalline lens.